BioCentury
ARTICLE | Financial News

Medivation to implement stock split

August 28, 2012 11:26 PM UTC

Medivation Inc. (NASDAQ:MDVN) announced late Tuesday a two-for-one stock split for shareholders on record as of Sept. 7. The split will take effect on Sept. 21. Medivation has 36.8 million shares outstanding. Medivation said its board believes the split will make the stock more affordable and attractive to a broader group of potential investors, and increase liquidity in trading. The company cited the stock's 482% increase since data were released in November 2011 showing enzalutamide met the primary endpoint of median overall survival (OS) in the Phase III AFFIRM trial to treat castration-resistant prostate cancer (CRPC) (see BioCentury, Nov. 7, 2011). ...